鞣花酸对印度幽门螺杆菌分离株的抗菌活性及小鼠感染模型中的效果
研究评估鞣花酸对55株来自印度的幽门螺杆菌临床分离株的体外抗菌活性,并用透射电镜观察形态变化;同时在幽门螺杆菌SS1感染的小鼠模型中评估其根除感染和修复胃黏膜损伤的效果。结果显示鞣花酸抑制全部55株菌生长,MIC为5-30 mg/L,在体内模型中可根除幽门螺杆菌并促进胃黏膜损伤修复。
要点
- 鞣花酸抑制全部55株幽门螺杆菌临床分离株的生长,MIC为5-30 mg/L。
- 在小鼠感染模型中,鞣花酸可根除幽门螺杆菌并修复胃黏膜损伤。
- 作者认为鞣花酸可作为有前景的抗幽门螺杆菌抗菌剂。
核心结论
- 鞣花酸在体外抑制全部55株幽门螺杆菌生长,MIC为5-30 mg/L,并在小鼠模型中根除感染、修复胃黏膜损伤,作者认为其可作为有前景的抗幽门螺杆菌抗菌剂。
研究设计与样本
- 共筛选55株幽门螺杆菌临床分离株,采用琼脂稀释法测定药物敏感性,透射电镜观察鞣花酸处理后的形态。
- 在幽门螺杆菌SS1感染的小鼠(C57BL/6)模型中,通过组织学和PCR评估鞣花酸的抗菌活性及对胃黏膜损伤的影响。
主要发现
- 鞣花酸抑制全部55株受试幽门螺杆菌菌株的生长,MIC范围为5-30 mg/L,体外显示杀菌特性。
- 在体内模型中,鞣花酸根除幽门螺杆菌感染,并促进幽门螺杆菌所致胃黏膜损伤的恢复和修复。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Because of the rise in antimicrobial resistance, an inexpensive, diet-based treatment against Helicobacter pylori infection would be of great interest. The present study was performed to assess the in vitro effects of ellagic acid against clinical H. pylori strains that were resistant to antibiotics used for therapy and also to observe the morphological structure following treatment with ellagic acid. The effectiveness of ellagic acid in eradicating H. pylori infection in a murine (C57BL/6) infection model, one of the standard inbred mouse lines often used for experimental infection, was also assessed. METHODS: A total of 55 strains were screened. The agar dilution method was used to determine the susceptibility of isolates to test compounds. Transmission electron microscopy was used to observe the morphology following treatment with ellagic acid. The antibacterial activity of ellagic acid in an H. pylori SS1-infected mouse model and its effect on gastric mucosal injury were determined by histology and PCR. RESULTS: Ellagic acid inhibited the growth of all 55 of the H. pylori strains tested. The MIC of ellagic acid ranged from 5 to 30 mg/L, showing its bactericidal properties in vitro. Ellagic acid also demonstrated anti-H. pylori efficacy in eradication of this organism in an in vivo model, as well as restitution and repair of H. pylori-induced gastric mucosal damage. CONCLUSIONS: The present study paves the way for the preventive and therapeutic use of ellagic acid against H. pylori infection and, thus, ellagic acid can be considered a promising antibacterial agent against H. pylori-associated gastroduodenal diseases in humans.
引用
- De R, Sarkar A, Ghosh P, et al. Antimicrobial activity of ellagic acid against Helicobacter pylori isolates from India and during infections in mice. J Antimicrob Chemother. 2018. PMID: 29566160. doi:10.1093/jac/dky079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。